Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Allinaire Therapeutics LLC
Profile last edited on: 5/15/18      CAGE: 7KPN9      UEI: K5GFMW6QF1P7

Business Identifier: Therapeutics for chronic obstructive pulmonary disease and other pulmonary diseases
Year Founded
2015
First Award
2018
Latest Award
2018
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

20600 Chagrin Boulevard Suite 210
Cleveland, OH 44122
   (216) 455-3208
   N/A
   www.allinaire.com
Location: Multiple
Congr. District: 11
County: 

Public Profile

Anchored in the discovery by the firm's scientific founders of a novel therapeutic target that could play a central role in the development and progression of lung disease, Allinaire Therapeutics is organized around development of novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases. It has been demonstrated that a therapeutic antibody against this target has a strong potential as a disease - modifying treatment to slow the progression of COPD.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$281,155
Phase II Dollars
$0
Total Awarded
$281,155

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2018 1 NIH $281,155
Project Title: Humanized EMAP II MAB as a Novel Therapy for Viral-Associated Lung Injury

Key People / Management

  Elizabeth Berezovsky -- Project Manager

  Matthias Clauss -- Scientiic Founder

  Angela Corona

  Douglas Hay -- Project Director

  Wade Lange -- FOUNDER & SENIOR ADVISER

  Christa Pawlowski -- Project Operations Director

  Rina Petrache -- Scientific Founder

Company News

Dec 20 2016
Development of a Fully Humanized Antibody for Treating Lung Emphysema